EAM
RARX
Eventide Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-743,000
| Closed | -$17.6M | – | 138 |
|
|
2019
Q3 | $17.6M | Hold |
743,000
| – | – | 0.58% | 60 |
|
|
2019
Q2 | $22.3M | Buy |
743,000
+383,100
| +106% | +$11.5M | 0.68% | 54 |
|
|
2019
Q1 | $8.06M | Sell |
359,900
-28,100
| -7% | -$629K | 0.28% | 80 |
|
|
2018
Q4 | $7.06M | Hold |
388,000
| – | – | 0.31% | 80 |
|
|
2018
Q3 | $7.02M | Hold |
388,000
| – | – | 0.26% | 91 |
|
|
2018
Q2 | $3.86M | Hold |
388,000
| – | – | 0.16% | 96 |
|
|
2018
Q1 | $2.06M | Buy |
+388,000
| New | +$2.06M | 0.1% | 111 |
|
|
2017
Q4 | – | Sell |
-100,000
| Closed | -$1.46M | – | 148 |
|
|
2017
Q3 | $1.46M | Hold |
100,000
| – | – | 0.08% | 112 |
|
|
2017
Q2 | $1.87M | Buy |
+100,000
| New | +$1.87M | 0.12% | 98 |
|